← Open Payments lookup

TANESHA GULLEY: Open Payments

NPI 1932743655 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$511 in 19 payments from 10 companies in 2025. Trend: 2023 $1,057 · 2024 $264 · 2025 $511

Food & beverage: $511
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$156
Novartis Pharmaceuticals Corporation6$125
PFIZER INC.2$53
Takeda Pharmaceuticals U.S.A., Inc.1$40
Janssen Biotech, Inc.1$35
Stemline Therapeutics Inc.1$29
Lilly USA, LLC1$25
Myriad Genetic Laboratories, Inc.1$19
Gilead Sciences, Inc.1$16
Daiichi Sankyo Inc.1$14

Products named: Fabhalta, ENHERTU, IBRANCE, FRUZAQLA, ERLEADA, Orserdu, SCEMBLIX, VERZENIO.

Industry payments across GA — which companies pay providers there.